跳至主要内容
临床试验/JPRN-UMIN000005205
JPRN-UMIN000005205已完成未知

Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: AF Suppression Trial - SILK

Kumamoto University School of Medicine University Hospital, Department of Cardiac Arrhythmias0 个研究点目标入组 154 人开始时间: 2011年3月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
154

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Key exclusion criteria Patients were excluded from the study on the basis of the following criteria: contraindications to treatment with irbesartan or amlodipine; myocardial infarction during the previous 3 months; cardiac surgery during the previous 3 months; bradycardia<50 bpm while the patient was awake; unstable angina: NYHA heart failure class not less than III: QT interval not less than 480 ms in the absence of bundle-branch block; significant impairment of renal function: significant hepatic disease.

研究者

发起方
Kumamoto University School of Medicine University Hospital, Department of Cardiac Arrhythmias

相似试验